US Broker Ratings

Evolent Health, Inc (EVH) Stock Analysis: Navigating a 33.9% Potential Upside in Healthcare Innovation

Evolent Health, Inc. (NASDAQ: EVH), a prominent player in the health information services industry, has positioned itself as a key innovator in the U.S. healthcare sector...

Immunovant, Inc. (IMVT) Stock Analysis: Exploring a 171% Potential Upside in Biotech

Immunovant, Inc. (NASDAQ: IMVT), a clinical-stage biotechnology company focused on developing monoclonal antibodies for autoimmune diseases, is attracting significant attention from investors. With a market capitalization..

agilon health, inc. (AGL) Stock Analysis: Unveiling an 84.94% Upside Potential in Healthcare

agilon health, inc. (NYSE: AGL), a prominent player in the healthcare sector, stands at a fascinating juncture with substantial upside potential of 84.94% according to analyst..

Celldex Therapeutics (CLDX) Stock Analysis: A High-Potential Play with 187.66% Upside

Celldex Therapeutics, Inc. (NASDAQ: CLDX) is capturing attention in the biotechnology sector with a promising pipeline focused on severe inflammatory, allergic, and autoimmune diseases. As a..

Novavax, Inc. (NVAX) Investor Outlook: 113% Potential Upside Amidst Biotech Volatility

In the dynamic landscape of biotechnology, Novavax, Inc. (NASDAQ: NVAX) presents a compelling, albeit risky, opportunity for investors seeking exposure to the healthcare sector. With a..

SS Innovations International (SSII) Stock Analysis: Navigating the Robotics Revolution in Healthcare

In the rapidly evolving healthcare sector, SS Innovations International Inc. (SSII) stands out as a key player in the medical devices industry, driven by its innovative..

Arcutis Biotherapeutics, Inc. (ARQT) Stock Analysis: Impressive 50.8% Potential Upside Awaits Investors

Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) is drawing attention in the investor community, especially those with an eye on the healthcare sector. The biopharmaceutical company, based in..

GoodRx Holdings, Inc. (GDRX) Stock Analysis: Exploring a Potential 26.84% Upside for Investors

GoodRx Holdings, Inc. (NASDAQ: GDRX) presents an intriguing opportunity for investors seeking exposure in the healthcare sector, specifically within the realm of health information services. With..

Merus N.V. (MRUS) Stock Analysis: Unpacking the 71.48% Potential Upside

Merus N.V. (NASDAQ: MRUS), a prominent player in the biotechnology sector, has captured the attention of investors with its innovative approach to developing antibody therapeutics. Based..

Protagonist Therapeutics, Inc. (PTGX) Investor Outlook: Analyzing a 24.84% Potential Upside in the Biotechnology Sector

Investors eyeing opportunities in the biotechnology sector should consider Protagonist Therapeutics, Inc. (NASDAQ: PTGX), a company with a market capitalization of $3.43 billion. Operating within the..

Guardian Pharmacy Services, Inc (GRDN) Stock Analysis: Exploring a 28% Upside Potential

Guardian Pharmacy Services, Inc (NASDAQ: GRDN), a prominent player in the healthcare sector, operates within the critical niche of medical care facilities in the United States...

Teladoc Health, Inc. (TDOC) Stock Analysis: Navigating the Virtual Healthcare Landscape with a Free Cash Flow Focus

Teladoc Health, Inc. (NYSE: TDOC) stands as a prominent player in the virtual healthcare sector, a field poised for significant growth as digital health solutions continue..

Apogee Therapeutics, Inc. (APGE) Investor Outlook: Exploring a 116% Potential Upside

For investors eyeing opportunities in the biotechnology sector, Apogee Therapeutics, Inc. (NASDAQ: APGE) is a name that stands out, primarily due to its compelling potential upside..

Integra LifeSciences Holdings C (IART) Stock Analysis: Evaluating a 31.42% Potential Upside in the Medical Device Sector

Integra LifeSciences Holdings Corporation (NASDAQ: IART), a key player in the medical device sector, presents an intriguing proposition for investors seeking exposure to healthcare innovation. With..

MannKind Corporation (MNKD): Analyst Consensus and 152% Potential Upside Highlight Growth Potential

MannKind Corporation (NASDAQ: MNKD) is drawing significant attention from the investment community, and for good reason. With a market capitalization of $1.14 billion, this biopharmaceutical company..

Omnicell, Inc. (OMCL) Stock Analysis: Unlocking a 35% Potential Upside in the Health Information Services Sector

As Omnicell, Inc. (NASDAQ: OMCL) continues to make strides in the healthcare sector, investors are eyeing the potential upside that could reach an impressive 35.49%. With..

Harmony Biosciences Holdings (HRMY): A 63% Potential Upside Amid Expansive Neurological Pipeline

Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY) presents a compelling opportunity for investors seeking exposure in the biotechnology sector, particularly with its focus on addressing rare and..

Structure Therapeutics Inc. (GPCR): Unveiling the 268% Potential Upside in Biotech Innovation

Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company, is capturing the attention of investors with a remarkable 267.99% potential upside according to analyst ratings...

CRISPR Therapeutics AG (CRSP) Stock Analysis: Unveiling a 68% Potential Upside with Cutting-Edge Gene Editing Technology

CRISPR Therapeutics AG (NASDAQ: CRSP), a pioneering force in the biotechnology industry, continues to capture investor attention with its groundbreaking gene-editing technologies. As a Swiss-based company,..

BGM Group Ltd. (BGM): Navigating Challenges in the Healthcare Sector Amidst Revenue Decline

BGM Group Ltd. (BGM), a key player in China’s healthcare sector, specializes in the manufacturing and distribution of active pharmaceutical ingredients (APIs) and traditional Chinese medicine..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds